WeVote
Log In

Bill

Bill

HB 1460

An Act Providing for approval from the Department of Health and the Office of Attorney General before certain transactions involving health care entities within this Commonwealth.

2025-2026 Regular Session Introduced by Lisa Borowski and 31 co-sponsors

Pennsylvania requires Department of Health and Attorney General approval for healthcare entity transactions to protect public interest and competition in healthcare markets.

First consideration
0
WeVote Research Nonpartisan
Bill Summary · HB 1460

Legislative bill overview

HB 1460 requires Pennsylvania healthcare entities to obtain approval from both the Department of Health and the Office of Attorney General before executing certain transactions. The bill establishes a regulatory review process that aims to ensure such transactions serve the public interest and comply with state healthcare policy objectives.

Why is this important

Healthcare transactions—including mergers, acquisitions, and major asset transfers—can significantly affect service availability, pricing, and competition in local markets. This approval requirement creates a state-level oversight mechanism to prevent transactions that might harm public health access or create monopolistic conditions, giving regulators explicit authority to block or condition deals they deem problematic.

Potential points of contention

  • Business regulatory burden: Healthcare organizations and investors argue the dual-approval requirement creates uncertainty, delays deal timelines, and may discourage investment or consolidation that could improve efficiency
  • Standards ambiguity: The bill does not clearly define what transactions require approval or what criteria regulators should use to approve/deny them, potentially leading to inconsistent enforcement or litigation
  • Market impact trade-offs: While oversight protects consumers, it may prevent beneficial consolidations (such as struggling hospitals merging with stronger systems) or limit competition-enhancing transactions that regulators might overly restrict

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.